“…The overall sample size within the included articles was 4,868 participants (minimum = 40, maximum = 1,686, average = 608.5). Two articles were published in 2022 [ 15 , 16 ], three articles were published in 2021 [ 13 , 14 , 20 ], one article was published in 2019 [ 17 ], one article was published in 2018 [ 19 ], and one article was published in 2006 [ 18 ]. The studies were conducted in different places in Saudi Arabia, as follows: Taif city [ 16 ], outpatient clinics and the daycare unit in a tertiary care hospital in south-western Saudi Arabia [ 15 ], different hospitals in Saudi Arabia [ 14 ], a non-profit professional Saudi pharmaceutical society [ 13 ], King Abdulaziz University [ 20 ], the rheumatology department of Al-Ameen Hospital in Taif [ 17 ], a single academic institution in Riyadh [ 19 ], and a teaching hospital in Jeddah [ 18 ].…”